William F. Kiesman

956 total citations
32 papers, 718 citations indexed

About

William F. Kiesman is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, William F. Kiesman has authored 32 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 12 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in William F. Kiesman's work include Adenosine and Purinergic Signaling (7 papers), Synthesis and Biological Evaluation (6 papers) and Asymmetric Synthesis and Catalysis (5 papers). William F. Kiesman is often cited by papers focused on Adenosine and Purinergic Signaling (7 papers), Synthesis and Biological Evaluation (6 papers) and Asymmetric Synthesis and Catalysis (5 papers). William F. Kiesman collaborates with scholars based in United States, Switzerland and Belgium. William F. Kiesman's co-authors include Mark J. Burk, John G. Allen, Jeff Zablocki, Elfatih Elzein, Russell C. Petter, Xianglin Shi, Zhili Xin, Patrick R. Conlon, Xiaowei Jin and Glenn J. Smits and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

William F. Kiesman

32 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William F. Kiesman United States 16 397 284 142 108 57 32 718
Ronald T. Wester United States 15 274 0.7× 272 1.0× 24 0.2× 53 0.5× 19 0.3× 20 806
Jürg R. Pfister United States 12 361 0.9× 168 0.6× 71 0.5× 31 0.3× 8 0.1× 21 553
Yasuyoshi Arikawa Japan 12 448 1.1× 204 0.7× 13 0.1× 201 1.9× 42 0.7× 23 843
Paula A. Bracco Brazil 14 122 0.3× 310 1.1× 30 0.2× 34 0.3× 79 1.4× 32 590
William C. Patt United States 13 510 1.3× 281 1.0× 78 0.5× 25 0.2× 6 0.1× 23 804
Vı́ctor Segarra Spain 16 500 1.3× 385 1.4× 41 0.3× 14 0.1× 16 0.3× 41 899
Jeffrey S. Sabol United States 13 694 1.7× 264 0.9× 21 0.1× 103 1.0× 6 0.1× 24 961
John B. Feltenberger United States 15 408 1.0× 225 0.8× 20 0.1× 41 0.4× 15 0.3× 23 764
Leszek Szmigiero Poland 15 222 0.6× 357 1.3× 13 0.1× 25 0.2× 19 0.3× 53 697
Conrad Santini United States 17 408 1.0× 493 1.7× 9 0.1× 46 0.4× 24 0.4× 30 883

Countries citing papers authored by William F. Kiesman

Since Specialization
Citations

This map shows the geographic impact of William F. Kiesman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Kiesman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Kiesman more than expected).

Fields of papers citing papers by William F. Kiesman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Kiesman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Kiesman. The network helps show where William F. Kiesman may publish in the future.

Co-authorship network of co-authors of William F. Kiesman

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Kiesman. A scholar is included among the top collaborators of William F. Kiesman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Kiesman. William F. Kiesman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hæffner, Fredrik, et al.. (2022). The Chelate Effect Rationalizes Observed Rate Acceleration and Enantioselectivity in BINOL‐Catalyzed Petasis Reactions. Chemistry - A European Journal. 29(13). e202203331–e202203331. 2 indexed citations
2.
Kiesman, William F., A. McPherson, Louis J. Diorazio, et al.. (2021). Perspectives on the Designation of Oligonucleotide Starting Materials. Nucleic Acid Therapeutics. 31(2). 93–113. 12 indexed citations
3.
Li, Chaomin, Michael Humora, Bin Ma, et al.. (2020). Process Development and Large-Scale Synthesis of BTK Inhibitor BIIB068. Organic Process Research & Development. 24(6). 1199–1206. 4 indexed citations
4.
Yang, Jimin, Jessica A. Stolee, Hong Jiang, et al.. (2018). Solid-Phase Synthesis of Phosphorothioate Oligonucleotides Using Sulfurization Byproducts for in Situ Capping. The Journal of Organic Chemistry. 83(19). 11577–11585. 20 indexed citations
5.
Shi, Xianglin, et al.. (2015). Process Development of an N-Benzylated Chloropurine at the Kilogram Scale. Organic Process Research & Development. 19(3). 437–443. 4 indexed citations
6.
Faul, Margaret M., Magnus Eriksson, Zhihong Ge, et al.. (2015). Part 3: Designation and Justification of API Starting Materials: Proposed Framework for Alignment from an Industry Perspective. Organic Process Research & Development. 19(8). 915–924. 13 indexed citations
7.
Faul, Margaret M., William F. Kiesman, Steven I. Pfeiffer, et al.. (2014). Part 1: A Review and Perspective of the Regulatory Guidance to Support Designation and Justification of API Starting Material. Organic Process Research & Development. 18(5). 587–593. 12 indexed citations
8.
Faul, Margaret M., Carl A. Busacca, Magnus Eriksson, et al.. (2014). Part 2: Designation and Justification of API Starting Materials: Current Practices across Member Companies of the IQ Consortium. Organic Process Research & Development. 18(5). 594–600. 12 indexed citations
9.
Thomson, Nicholas M., Kevin D. Seibert, Srinivas Tummala, et al.. (2014). Case Studies in the Applicability of Drug Substance Design Spaces Developed on the Laboratory Scale to Commercial Manufacturing. Organic Process Research & Development. 19(8). 925–934. 5 indexed citations
10.
Shi, Xianglin, William F. Kiesman, Anna Levina, & Zhili Xin. (2013). Catalytic Asymmetric Petasis Reactions of Vinylboronates. The Journal of Organic Chemistry. 78(18). 9415–9423. 28 indexed citations
11.
Kiesman, William F., Elfatih Elzein, & Jeff Zablocki. (2009). A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers. Handbook of experimental pharmacology. 25–58. 77 indexed citations
12.
Chang, Hexi, William F. Kiesman, & Russell C. Petter. (2007). Convenient One‐Pot Preparation of Dimethyl Bicyclo[2.2.2]octane‐1,4‐dicarbolylate, a Key Intermediate for a Novel Adenosine A1 Receptor Antagonist. Synthetic Communications. 37(8). 1267–1272. 5 indexed citations
13.
Kiesman, William F., Jin Zhao, Patrick R. Conlon, et al.. (2006). Norbornyllactone-substituted xanthines as adenosine A1 receptor antagonists. Bioorganic & Medicinal Chemistry. 14(11). 3654–3661. 16 indexed citations
14.
Vu, Chi B., William F. Kiesman, Patrick R. Conlon, et al.. (2006). Tricyclic Imidazoline Derivatives as Potent and Selective Adenosine A1Receptor Antagonists. Journal of Medicinal Chemistry. 49(24). 7132–7139. 13 indexed citations
15.
Auchampach, John A., Xiaowei Jin, Jeannine Moore, et al.. (2004). Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs. Journal of Pharmacology and Experimental Therapeutics. 308(3). 846–856. 36 indexed citations
16.
Yao, Gang, Sha Li, G. Kumaravel, et al.. (2004). Synthesis of alkyne derivatives of a novel triazolopyrazine as A2A adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 511–515. 47 indexed citations
17.
Burk, Mark J., et al.. (1999). Catalytic asymmetric hydrogenation of β-substituted α,β,γ,δ-unsaturated amino acids. Tetrahedron Letters. 40(16). 3093–3096. 32 indexed citations
18.
Burk, Mark J., et al.. (1997). A convenient cross-coupling route to α,β,γ,δ-unsaturated amino acids. Tetrahedron Letters. 38(8). 1309–1312. 22 indexed citations
19.
Kiesman, William F., et al.. (1997). Detection of Aryl Radicals in Hydrodediazoniations. The Journal of Organic Chemistry. 62(24). 8304–8308. 28 indexed citations
20.
Kiesman, William F., et al.. (1995). Deuteriodediazoniation: A general method for the replacement of a diazonium group by deuterium. Journal of Labelled Compounds and Radiopharmaceuticals. 36(3). 281–288. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald T. Wester Breakdown of academic impact, for papers by Jürg R. Pfister Breakdown of academic impact, for papers by Yasuyoshi Arikawa Breakdown of academic impact, for papers by Paula A. Bracco Breakdown of academic impact, for papers by William C. Patt Breakdown of academic impact, for papers by Vı́ctor Segarra Breakdown of academic impact, for papers by Jeffrey S. Sabol Breakdown of academic impact, for papers by John B. Feltenberger Breakdown of academic impact, for papers by Leszek Szmigiero Breakdown of academic impact, for papers by Conrad Santini
Rankless by CCL
2026